CJC-1295 no DAC+Ipamorelin
$120.00Price
CJC-1295 + Ipamorelin is a dual-peptide research blend commonly studied for its interaction with growth hormone–related signaling pathways and endocrine system regulation. This combination is widely utilized in laboratory environments to explore synergistic effects on hormonal signaling, peptide receptor activity, and metabolic processes.
CJC-1295 is a growth hormone–releasing hormone (GHRH) analog studied for its role in stimulating hormone signaling pathways, while Ipamorelin is a selective growth hormone secretagogue studied for its interaction with ghrelin receptors. Together, they are frequently researched for their combined influence on endocrine function and peptide-based signaling mechanisms.
